Impact of Watercress Consumption on Antioxidant Defense and Oxidative Stress Among Adults with Different Levels of Exposure to Cigarette Smoke in Chiang Mai, Thailand
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Population and Ethical Approval
2.2. Study Design and Blood Sample Collection
2.3. Blood Sample Preparation
2.4. Antioxidant Capacity and Biomarker of Oxidative Stress Analysis
2.4.1. Plasma Total Antioxidant Capacity (FRAP Method and ABTS Enzyme Method)
2.4.2. Determination of Oxidative Stress Markers by CAT Activity and MDA in Plasma Samples
2.5. Statistical Analysis
3. Results
3.1. Baseline Demographic Characteristics
3.2. Smoking Behavior, SHS Exposure, and Exhaled CO Levels
3.3. Physical Examination and Blood Pressure Results
3.4. Comparison of Biochemical Parameters
3.5. Analysis of Antioxidant Capacity and Oxidative Stress Markers
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| ABTS | 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid |
| BMI | Body mass index |
| CAT | Catalase |
| CO | Carbon monoxide |
| COPD | Chronic obstructive pulmonary disease |
| EOT | End of treatment (watercress consumption) |
| FBG FDA | Fasting blood glucose Food and Drug Administration |
| FRAP | Ferric reducing antioxidant power |
| H2O2 | Hydrogen peroxide |
| HDL-C | High-density lipoprotein cholesterol |
| HO• | Hydroxyl radical |
| IL-10 | Interleukin-10 |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IQR | Interquartile range |
| ITCs | Isothiocyanates |
| LDL-C | Low-density lipoprotein cholesterol |
| MDA | Malondialdehyde |
| NCDs | Non-communicable diseases |
| NO• | Nitric oxide radical |
| O2•− | Superoxide anion radical |
| ROS | Reactive oxygen species |
| SHS | Non-smoker exposure to secondhand smoke |
| TAC | Total antioxidant capacity |
| TBA | Thiobarbituric acid |
| TC | Total cholesterol |
| TG | Triglyceride |
| TNF-α | Tumor necrosis factor-alpha |
| TPTZ | Triphenyltriazine |
References
- Li, Y.; Hecht, S.S. Carcinogenic components of tobacco and tobacco smoke: A 2022 update. Food Chem. Toxicol. 2022, 165, 113179. [Google Scholar] [CrossRef]
- US Food and Drug Administration. Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Fed Regist. 2012, 77, 20034–20037. [Google Scholar]
- Seenak, P.; Nernpermpisooth, N.; Kumphune, S.; Songjang, W.; Jiraviriyakul, A.; Jumroon, N.; Pankhong, P.; Roytrakul, S.; Thaisakun, S.; Phaonakrop, N.; et al. Secretome profiling of human epithelial cells exposed to cigarette smoke extract and their effect on human lung microvascular endothelial cells. Sci. Rep. 2024, 14, 13740. [Google Scholar] [CrossRef]
- Serrano-Gotarredona, M.P.; Navarro-Herrero, S.; Gómez-Izquierdo, L.; Rodríguez-Portal, J.A. Smoking-related interstitial lung disease. Radiologia (Engl. Ed.) 2022, 64 (Suppl. S3), 277–289. [Google Scholar] [CrossRef]
- Ishida, M.; Sakai, C.; Kobayashi, Y.; Ishida, T. Cigarette Smoking and Atherosclerotic Cardiovascular Disease. J. Atheroscler. Thromb. 2024, 31, 189–200. [Google Scholar] [CrossRef]
- Obore, N.; Kawuki, J.; Guan, J.; Papabathini, S.S.; Wang, L. Association between indoor air pollution, tobacco smoke and tuberculosis: An updated systematic review and meta-analysis. Public Health 2020, 187, 24–35. [Google Scholar] [CrossRef]
- Thawanaphong, S.; Nair, P. Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease. Respirology 2025, 30, 574–586. [Google Scholar] [CrossRef] [PubMed]
- Sierra-Vargas, M.P.; Montero-Vargas, J.M.; Debray-García, Y.; Vizuet-de-Rueda, J.C.; Loaeza-Román, A.; Terán, L.M. Oxidative Stress and Air Pollution: Its Impact on Chronic Respiratory Diseases. Int. J. Mol. Sci. 2023, 24, 853. [Google Scholar] [CrossRef] [PubMed]
- Rajagopalan, S.; Brook, R.D.; Salerno, P.; Bourges-Sevenier, B.; Landrigan, P.; Nieuwenhuijsen, M.J.; Munzel, T.; Deo, S.V.; Al-Kindi, S. Air pollution exposure and cardiometabolic risk. Lancet Diabetes Endocrinol. 2024, 12, 196–208. [Google Scholar] [CrossRef] [PubMed]
- Sharifi-Rad, M.; Anil Kumar, N.V.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Tsouh Fokou, P.V.; Azzini, E.; Peluso, I.; et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020, 11, 694. [Google Scholar] [CrossRef]
- Han, M.; Lee, D.; Lee, S.H.; Kim, T.H. Oxidative Stress and Antioxidant Pathway in Allergic Rhinitis. Antioxidants 2021, 10, 1266. [Google Scholar] [CrossRef]
- Li, D.; Ding, Z.; Du, K.; Ye, X.; Cheng, S. Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy. Oxid. Med. Cell Longev. 2021, 2021, 5583215. [Google Scholar] [CrossRef]
- Anwar, H.; Hussain, G.; Mustafa, I. Antioxidants from Natural Sources. Antioxid. Foods Its Appl. 2018, 3–28. [Google Scholar] [CrossRef]
- Panahi Kokhdan, E.; Khodabandehloo, H.; Ghahremani, H.; Doustimotlagh, A.H. A Narrative Review on Therapeutic Potentials of Watercress in Human Disorders. Evid. Based Complement Alternat. Med. 2021, 2021, 5516450. [Google Scholar] [CrossRef]
- Kijkuokool, P.; Stepanov, I.; Ounjaijean, S.; Koonyosying, P.; Rerkasem, K.; Chuljerm, H.; Parklak, W.; Kulprachakarn, K. Effects of Drying Methods on the Phytochemical Contents, Antioxidant Properties, and Anti-Diabetic Activity of Nasturtium officinale R.Br. (Betong Watercress) from Southern Thailand. Life 2024, 14, 1204. [Google Scholar] [CrossRef]
- Kyriakou, S.; Michailidou, K.; Amery, T.; Stewart, K.; Winyard, P.G.; Trafalis, D.T.; Franco, R.; Pappa, A.; Panayiotidis, M.I. Polyphenolics, glucosinolates and isothiocyanates profiling of aerial parts of Nasturtium officinale (Watercress). Front. Plant Sci. 2022, 13, 998755. [Google Scholar] [CrossRef] [PubMed]
- Chiș, M.S.; Păucean, A.; Man, S.M.; Petruț, G.; Mureșan, A.E.; Pop, A.; Pop, C.R.; Muste, S. Watercress (Nasturtium officinale R. Br.) chemical compositions and applications in food processing. Hop. Med. Plants 2020, 28, 59–68. [Google Scholar] [CrossRef]
- Clemente, M.; Miguel, M.; Gribner, C.; Moura, P.F.; Angelica, A.; Rigoni, R.; Fernandes, L.C.; Miguel, O.G. Watercress as a functional food with protective effects on human health against oxidative stress: A review study. Int. J. Med. Plants Nat. Prod. 2019, 5, 12–16. [Google Scholar] [CrossRef]
- Maluwa, C.; Zinan’dala, B.; Chuljerm, H.; Parklak, W.; Kulprachakarn, K. Watercress (Nasturtium officinale) as a Functional Food for Non-Communicable Diseases Prevention and Management: A Narrative Review. Life 2025, 15, 1104. [Google Scholar] [CrossRef]
- Hecht, S.; Borukhova, A.; Skowronski, L.; Carmella, G.; Richie, P. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol. Biomark. Prev. 1995, 4, 877–885. [Google Scholar]
- Spínola, V.; Pinto, J.; Castilho, P.C. In vitro studies on the effect of watercress juice on digestive enzymes relevant to type 2 diabetes and obesity and antioxidant activity. J. Food Biochem. 2017, 41, e12335. [Google Scholar] [CrossRef]
- Hadjzadeh, M.A.; Rajaei, Z.; Moradi, R.; Ghorbani, A. Effects of Hydroalcoholic Extract of Watercress (Nasturtium officinale) Leaves on Serum Glucose and Lipid Levels in Diabetic Rats. Indian J. Physiol. Pharmacol. 2015, 59, 223–230. [Google Scholar] [PubMed]
- Shokraei, S.; Khandouzi, N.; Sina, Z.; Nasrollahzadeh, J. The acute effect of incorporating lettuce or watercress into a moderately high-fat meal on postprandial lipid, glycemic response, and plasma inflammatory cytokines in healthy young men: A randomized crossover trial. Lipids Health Dis. 2021, 20, 66. [Google Scholar] [CrossRef]
- Bahramikia, S.; Yazdanparast, R. Effect of hydroalcoholic extracts of Nasturtium officinale leaves on lipid profile in high-fat diet rats. J. Ethnopharmacol. 2008, 115, 116–121. [Google Scholar] [CrossRef]
- Clemente, M.; Miguel, M.D.; Felipe, K.B.; Gribner, C.; Moura, P.F.; Rigoni, A.A.R.; Parisotto, E.B.; Henneberg, R.; Dias, J.D.F.G.; Piltz, M.T.; et al. Effect of watercress extract supplementation on lipid profile and oxidative stress markers in overweight people with physical disability: A randomized, double-blind, and placebo-controlled trial. Phytother. Res. 2021, 35, 2211–2219. [Google Scholar] [CrossRef]
- Vicol, C.; Buculei, I.; Melinte, O.E.; Dobrin, M.E.; Stavarache, E.I.; Gavrilescu, C.-M.; Postolache, P.; Matei, D.; Trofor, A. The Lipid Profile and Biochemical Parameters of COPD Patients in Relation to Smoking Status. Biomedicines 2022, 10, 2936. [Google Scholar] [CrossRef]
- Patil, M.B.; James, J.V.; Somanath, B. Correlation of Lipid Profile Levels in Young Smokers and Nonsmokers with Special Reference to Coronary Artery Disease. J. Med. Sci. 2020, 6, 23–27. [Google Scholar] [CrossRef]
- Zakhar, J.; Amrock, S.M.; Weitzman, M. Passive and Active Tobacco Exposure and Children’s Lipid Profiles. Nicotine Tob. Res. 2016, 18, 982–987. [Google Scholar] [CrossRef] [PubMed]
- Sedighi, M.; Bahmani, M.; Asgary, S.; Beyranvand, F.; Rafieian-Kopaei, M. A review of plant-based compounds and medicinal plants effective on atherosclerosis. J. Res. Med. Sci. 2017, 22, 30. [Google Scholar] [CrossRef] [PubMed]
- Wang, H.X.; Ng, T.B. Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci. 1999, 65, 2663–2677. [Google Scholar] [CrossRef]
- Schulze, H.; Hornbacher, J.; Wasserfurth, P.; Reichel, T.; Günther, T.; Krings, U.; Krüger, K.; Hahn, A.; Papenbrock, J.; Schuchardt, J.P. Immunomodulating Effect of the Consumption of Watercress (Nasturtium officinale) on Exercise-Induced Inflammation in Humans. Foods 2021, 10, 1774. [Google Scholar] [CrossRef]
- Clemente, M.; Miguel, M.D.; Felipe, K.B.; Gribner, C.; Moura, P.F.; Rigoni, A.A.R.; Parisotto, E.B.; Piltz, M.T.; Valdameri, G.; Henneberg, R.; et al. Biomarkers of oxidative stress and inflammation in people with a physical disability treated with a standardized extract of Nasturtium officinale: A randomized, double-blind, and placebo-controlled trial. Phytother. Res. 2020, 34, 2756–2765. [Google Scholar] [CrossRef] [PubMed]
- Yang, R.L.; Shi, Y.H.; Hao, G.; Li, W.; Le, G.W. Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic Index. J. Clin. Biochem. Nutr. 2008, 43, 154–158. [Google Scholar] [CrossRef]
- Gill, C.I.; Haldar, S.; Boyd, L.A.; Bennett, R.; Whiteford, J.; Butler, M.; Pearson, J.R.; Bradbury, I.; Rowland, I.R. Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults. Am. J. Clin. Nutr. 2007, 85, 504–510. [Google Scholar] [CrossRef]
- Yildiz, L.; Kayaoğlu, N.; Aksoy, H. The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers. Clin. Chem. Lab. Med. 2002, 40, 612–615. [Google Scholar] [CrossRef]
- Wen, J.; Karabala, M.; Muttalib, Z.; Syed, B.; Khalil, R.; Razick, D.; Razick, A.; Pai, D. Evaluating the Antioxidant and Anti-Inflammatory Properties of Watercress Supplementation at Short-Term Follow-Up: A Systematic Review of Randomized Controlled Trials. Food Sci. Nutr. 2025, 13, e70407. [Google Scholar] [CrossRef]
- Nicikowski, J.; Reguła, J. Selected bioactive compounds in food of plant origin as natural immunomodulators in asthma and chronic obstructive pulmonary disease. Acta Sci. Pol. Technol. Aliment. 2021, 20, 383–397. [Google Scholar] [PubMed]
- Schaich, K.M.; Tian, X.; Xie, J. Hurdles and pitfalls in measuring antioxidant efficacy: A critical evaluation of ABTS, DPPH, and ORAC assays. J. Funct. Foods 2015, 14, 111–125. [Google Scholar] [CrossRef]


| Characteristic | Non-Smoker (n = 15) | SHS (n = 15) | Smoker (n = 15) | Total (n = 45) |
|---|---|---|---|---|
| Age (years), Mean ± SD | 36.47 ± 9.96 | 35.2 ± 9.74 | 38.4 ± 12.12 | 36.69 ± 10.5 |
| Gender, n (%) | ||||
| Male | 8 (53.3) | 5 (33.3) | 13 (86.7) | 26 (57.8) |
| Female | 7 (46.7) | 10 (66.7) | 2 (13.3) | 19 (42.2) |
| Education, n (%) | ||||
| Intermediate school | 0 (0.0) | 0 (0.0) | 2 (13.3) | 2 (4.4) |
| Junior high school | 1 (6.7) | 2 (13.3) | 5 (33.3) | 8 (17.8) |
| High school/vocational | 2 (13.3) | 3 (20.0) | 5 (33.3) | 10 (22.2) |
| Bachelor’s degree | 4 (26.7) | 9 (60.0) | 3 (20.0) | 16 (35.6) |
| Master’s degree | 5 (33.3) | 1 (6.7) | 0 (0.0) | 6 (13.3) |
| PhD degree | 3 (20.0) | 0 (0.0) | 0 (0.0) | 3 (6.7) |
| Occupation, n (%) | ||||
| Student | 2 (13.3) | 1 (6.7) | 0 (0.0) | 3 (6.7) |
| Employee | 6 (40.0) | 8 (53.3) | 9 (60.0) | 23 (51.1) |
| Government agencies | 6 (40.0) | 4 (26.7) | 2 (13.3) | 12 (26.7) |
| Self-employed | 1 (6.7) | 2 (13.3) | 3 (20.0) | 6 (13.3) |
| Other/housewife | 0 (0.0) | 0 (0.0) | 1 (6.7) | 1 (2.2) |
| Non-Smoker (n = 15) | SHS (n = 15) | Smoker (n = 15) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | EOT | p-Value | Baseline | EOT | p-Value | Baseline | EOT | p-Value | |
| Currently smoking, % | 0% | 0% | - | 0% | 0% | - | 100% | 100% | - |
| Duration of smoking (years), Median (IQR) | - | - | - | - | - | - | 10.51 (6.77–12.28) | - | - |
| Cigarettes per day, Median (IQR) a | - | - | - | - | - | - | 10 (5–10) | 7 (5–12) | 0.203 |
| Exposed to SHS (yes), % b | 0% | 0% | - | 100% | 93% | 1.000 | 0% | 0% | - |
| Frequency of SHS exposure (per week) b | - | - | - | - | - | 0.918 | - | - | - |
| 1 time, % | - | - | - | 6.7% | 7% | - | - | - | |
| 2–5 times, % | - | - | - | 46.7% | 36% | - | - | - | |
| 6–10 times, % | - | - | - | 40% | 50% | - | - | - | |
| >10 times, % | - | - | - | 6.7% | 7% | - | - | - | |
| Level of exhaled CO (ppm), Median (IQR) a | 2 (2–4) | 2 (2–3) | 0.699 | 3 (2–3) | 2 (2–3) | 0.109 | 16 (9–25) | 17 (9–27) | 0.423 |
| Characteristic | Watercress Consumption | Non-Smoker (n = 15) | SHS (n = 15) | Smoker (n = 15) | p-Value b |
|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Median (IQR) | |||
| Height (cm) | Baseline | 162.0 (156.0–170.0) | 164.5 (150.0–170.0) | 170.0 (160.0–176.0) | 0.190 |
| EOT | 163.0 (156.0–170.0) | 164.5 (150.0–170.0) | 170.0 (160.0–176.0) | 0.216 | |
| p-value a | 1.00 | 1.00 | 1.00 | ||
| Weight (kg) | Baseline | 61.50 (54.25–77.40) | 68.00 (53.75–73.50) | 65.90 (61.00–74.90) | 0.703 |
| EOT | 61.60 (54.70–76.60) | 68.00 (53.75–73.10) | 65.70 (60.55–75.70) | 0.748 | |
| p-value a | 0.445 | 0.480 | 0.382 | ||
| BMI (kg/m2) | Baseline | 24.8 (21.2–27.7) | 25.4 (21.0–28.4) | 23.5 (21.6–28.4) | 0.995 |
| EOT | 24.5 (21.2–27.7) | 25.0 (21.2–28.6) | 23.4 (21.7–28.3) | 0.980 | |
| p-value a | 0.012 * | 0.553 | 0.558 | ||
| Waist Circumference (cm) | Baseline | 80.0 (69.0–93.0) | 81.0 (72.0–91.0) | 83.0 (76.0–92.0) | 0.646 |
| EOT | 81.0 (74.0–91.6) | 86.0 (70.0–90.0) | 83.0 (81.0–89.6) | 0.610 | |
| p-value a | 0.836 | 1.000 | 0.570 | ||
| Hip Circumference (cm) | Baseline | 94.5 (91.0–104.0) | 98.0 (92.0–106.5) | 96.0 (90.5–101.0) | 0.682 |
| EOT | 96.0 (88.0–103.0) | 97.0 (92.0–104.0) | 96.0 (91.0–99.8) | 0.643 | |
| p-value a | 0.042 * | 0.213 | 0.690 | ||
| Systolic blood pressure (mmHg) | Baseline | 117 (100–127) | 125 (109–128) | 121 (113–133) | 0.480 |
| EOT | 117 (113–122) | 120 (114–125) | 124 (110–128) | 0.811 | |
| p-value a | 0.649 | 0.698 | 0.516 | ||
| Diastolic blood pressure (mmHg) | Baseline | 82 (68–89) | 85 (70–91) | 80 (74–90) | 0.715 |
| EOT | 82 (70–85) | 81 (72–88) | 82 (71–88) | 0.997 | |
| p-value a | 0.606 | 0.053 | 0.212 | ||
| Heart rate (bpm) | Baseline | 77 (67–83) | 72 (64–81) | 74 (69–79) | 0.577 |
| EOT | 73 (63–81) | 73 (68–81) | 75 (67–88) | 0.855 | |
| p-value a | 0.217 | 0.934 | 0.224 |
| Biochemical Parameters | Watercress Consumption | Non-Smoker (n = 15) | SHS (n = 15) | Smoker (n = 15) | p-Value b |
|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Median (IQR) | |||
| Fasting blood glucose, FBG (mg/dL) | Baseline | 91 (86–104) | 94 (84–102) | 91 (88–94) | 0.600 |
| EOT | 89 (84–104) | 89 (87–98) | 87 (78–92) | 0.214 | |
| p-value a | 0.656 | 0.324 | 0.075 | ||
| Total cholesterol, TC (mg/dL) | Baseline | 209 (170–242) | 230 (199–244) | 225 (187–253) | 0.567 |
| EOT | 206 (176–229) | 190 (159–216) | 152.1–207.76 | 0.345 | |
| p-value a | 0.525 | <0.001 * | 0.025 * | ||
| Triglyceride, TG (mg/dL) | Baseline | 92 (74–114) | 104 (78–160) | 129 (77–167) | 0.223 |
| EOT | 83 (61–137) | 98 (54–135) | 114 (71–156) | 0.521 | |
| p-value a | 0.772 | 0.258 | 0.283 | ||
| Low-density lipoprotein cholesterol, LDL-C (mg/dL) | Baseline | 139 (136–174) | 167 (109–197) | 174 (143–224) | 0.278 |
| EOT | 146 (135–166) | 119 (93–182) | 143 (104–174) | 0.603 | |
| p-value a | 0.561 | 0.017 * | 0.019 * | ||
| High-density lipoprotein cholesterol, HDL-C (mg/dL) | Baseline | 44.37 (33.94–50.48) | 45.46 (42.11–56.13) | 39.14 (34.40–49.83) | 0.143 |
| EOT | 44.04 (30.15–48.03) | 39.61 (30.96–51.97) | 34.91 (28.39–39.68) | 0.066 | |
| p-value a | 0.847 | 0.003 * | 0.055 |
| Biomarkers | Watercress Consumption | Non-Smoker (n = 15) | SHS (n = 15) | Smoker (n = 15) | p-Value b |
|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Median (IQR) | |||
| ABTS radical cation decolorization assay, ABTS (mmol/L) | Baseline | 5.91 (5.17–6.10) | 3.54 (2.59–4.72) | 4.60 (3.13–4.83) | 0.001 * |
| EOT | 3.54 (2.65–4.15) | 4.14 (3.32–4.84) | 4.11 (3.21–4.37) | 0.108 | |
| p-value a | <0.001 * | 0.083 | 0.561 | ||
| Ferric reducing antioxidant power, FRAP (mmol/L) | Baseline | 0.44 (0.40–0.54) | 0.43 (0.36–0.53) | 0.45 (0.41–0.52) | 0.765 |
| EOT | 0.49 (0.41–0.58) | 0.39 (0.36–0.54) | 0.49 (0.38–0.53) | 0.315 | |
| p-value a | 0.421 | 0.421 | 0.679 | ||
| Catalase, CAT (U/mL) | Baseline | 0.24 (0.15–0.39) | 0.39 (0.34–0.71) | 0.78 (0.56–0.83) | 0.006 * |
| EOT | 0.90 (0.48–2.00) | 1.82 (0.42–2.57) | 1.52 (0.34–2.67) | 0.796 | |
| p-value a | 0.016 * | 0.020 * | 0.039 * | ||
| Malondialdehyde, MDA (μmol/L) | Baseline | 24.67 (18.37–29.11) | 23.19 (14.67–28.37) | 15.41 (10.59–26.89) | 0.343 |
| EOT | 15.41 (9.85–29.85) | 17.26 (15.04–19.48) | 12.44 (6.52–19.48) | 0.185 | |
| p-value a | 0.041 * | 0.040 * | 0.006 * |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fakfum, P.; Kijkuokool, P.; Parklak, W.; Chuljerm, H.; Maluwa, C.; Stepanov, I.; Kulprachakarn, K. Impact of Watercress Consumption on Antioxidant Defense and Oxidative Stress Among Adults with Different Levels of Exposure to Cigarette Smoke in Chiang Mai, Thailand. Antioxidants 2025, 14, 1466. https://doi.org/10.3390/antiox14121466
Fakfum P, Kijkuokool P, Parklak W, Chuljerm H, Maluwa C, Stepanov I, Kulprachakarn K. Impact of Watercress Consumption on Antioxidant Defense and Oxidative Stress Among Adults with Different Levels of Exposure to Cigarette Smoke in Chiang Mai, Thailand. Antioxidants. 2025; 14(12):1466. https://doi.org/10.3390/antiox14121466
Chicago/Turabian StyleFakfum, Puriwat, Praporn Kijkuokool, Wason Parklak, Hataichanok Chuljerm, Chikondi Maluwa, Irina Stepanov, and Kanokwan Kulprachakarn. 2025. "Impact of Watercress Consumption on Antioxidant Defense and Oxidative Stress Among Adults with Different Levels of Exposure to Cigarette Smoke in Chiang Mai, Thailand" Antioxidants 14, no. 12: 1466. https://doi.org/10.3390/antiox14121466
APA StyleFakfum, P., Kijkuokool, P., Parklak, W., Chuljerm, H., Maluwa, C., Stepanov, I., & Kulprachakarn, K. (2025). Impact of Watercress Consumption on Antioxidant Defense and Oxidative Stress Among Adults with Different Levels of Exposure to Cigarette Smoke in Chiang Mai, Thailand. Antioxidants, 14(12), 1466. https://doi.org/10.3390/antiox14121466

